Skip to main content
Top
Published in: Critical Care 6/2006

01-12-2006 | Commentary

Seleno-enzymes and seleno-compounds: the two faces of selenium

Author: Xavier Forceville

Published in: Critical Care | Issue 6/2006

Login to get access

Abstract

Selenium protects cells and inhibits many inflammatory cell mechanisms through antioxidant seleno-enzymes. Immunity improvement is illustrated by the study of Berger and colleagues, with reduction of nosocomial pneumonia in burnt patients under multi-trace-element supplementation. As seleno-compounds (especially sodium selenite) are pro-oxidant, however, administration above 800 μg/day may be dangerous in septic shock. Paradoxically, direct reversible pro-oxidative effects of seleno-compounds may also be beneficial for reduction of inflammation (genomic action, apoptosis), and may even be bactericidal or virucidal. These facts need to be further examined, as well as the possible dramatic drop of plasma selenoprotein P in septic shock and its role in endothelium protection.
Literature
1.
go back to reference Berger MM, Eggimann P, Heyland DK, Chiolero RL, Revelly J-P, Day A, Raffoul W, Shenkin A: Reduction of nosocomial pneumonia after major burns by trace element supplementation: aggregation of two randomised trials. Crit Care 2006, 10: R153. 10.1186/cc5084PubMedCentralCrossRefPubMed Berger MM, Eggimann P, Heyland DK, Chiolero RL, Revelly J-P, Day A, Raffoul W, Shenkin A: Reduction of nosocomial pneumonia after major burns by trace element supplementation: aggregation of two randomised trials. Crit Care 2006, 10: R153. 10.1186/cc5084PubMedCentralCrossRefPubMed
2.
go back to reference Heyland DK, Dhaliwal R, Suchner U, Berger MM: Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med 2005, 31: 327-337. 10.1007/s00134-004-2522-zCrossRefPubMed Heyland DK, Dhaliwal R, Suchner U, Berger MM: Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med 2005, 31: 327-337. 10.1007/s00134-004-2522-zCrossRefPubMed
3.
go back to reference Avenell A, Noble DW, Barr J, Engelhardt T: Selenium supplementation for critically ill adults. Cochrane Database Syst Rev 2004, 4: CD003703.PubMed Avenell A, Noble DW, Barr J, Engelhardt T: Selenium supplementation for critically ill adults. Cochrane Database Syst Rev 2004, 4: CD003703.PubMed
4.
go back to reference Berger MM: Can oxidative damage be treated nutritionally? Clin Nutr 2005, 24: 172-183. 10.1016/j.clnu.2004.10.003CrossRefPubMed Berger MM: Can oxidative damage be treated nutritionally? Clin Nutr 2005, 24: 172-183. 10.1016/j.clnu.2004.10.003CrossRefPubMed
5.
go back to reference Angstwurm MW, Gaertner R: Practicalities of selenium supplementation in critically ill patients. Curr Opin Clin Nutr Metab Care 2006, 9: 233-238.CrossRefPubMed Angstwurm MW, Gaertner R: Practicalities of selenium supplementation in critically ill patients. Curr Opin Clin Nutr Metab Care 2006, 9: 233-238.CrossRefPubMed
6.
go back to reference Rayman MP: The importance of selenium to human health. Lancet 2000, 356: 233-241. 10.1016/S0140-6736(00)02490-9CrossRefPubMed Rayman MP: The importance of selenium to human health. Lancet 2000, 356: 233-241. 10.1016/S0140-6736(00)02490-9CrossRefPubMed
7.
go back to reference Selenium In Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and carotenoids. Edited by Panel on Dietary Antioxidants and Related Compounds, Interpretation and Uses of Dietary Reference Intakes, Institute of Medicine. Washington, DC: National Academy of Sciences; 2000:284-324. Selenium In Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and carotenoids. Edited by Panel on Dietary Antioxidants and Related Compounds, Interpretation and Uses of Dietary Reference Intakes, Institute of Medicine. Washington, DC: National Academy of Sciences; 2000:284-324.
8.
go back to reference Forceville X, Vitoux D: Selenium et sepsis. Nutr Clin Metab 1999, 13: 177-186.CrossRef Forceville X, Vitoux D: Selenium et sepsis. Nutr Clin Metab 1999, 13: 177-186.CrossRef
9.
go back to reference Forceville X, Vitoux D, Gauzit R, Combes A, Lahilaire P, Chappuis P: Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients [see comments]. Crit Care Med 1998, 26: 1536-1544. 10.1097/00003246-199809000-00021CrossRefPubMed Forceville X, Vitoux D, Gauzit R, Combes A, Lahilaire P, Chappuis P: Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients [see comments]. Crit Care Med 1998, 26: 1536-1544. 10.1097/00003246-199809000-00021CrossRefPubMed
10.
go back to reference Forceville X, Moster V, Vitoux D, Plouvier E, Lahilaire P, Combes A: Early marked selenoprotein P decrease in severe inflammatory and septic patients. In 1st International FESTEM Congress on Trace Elements and Minerals in Medicine and Biology; May 2001. Venice, Italy: Universita Ca Foscari; 2001:57. Forceville X, Moster V, Vitoux D, Plouvier E, Lahilaire P, Combes A: Early marked selenoprotein P decrease in severe inflammatory and septic patients. In 1st International FESTEM Congress on Trace Elements and Minerals in Medicine and Biology; May 2001. Venice, Italy: Universita Ca Foscari; 2001:57.
11.
go back to reference Burk RF, Hill KE, Boeglin ME, Ebner FF, Chittum HS: Selenoprotein P associates with endothelial cells in rat tissues. Histochem Cell Biol 1997, 108: 11-15. 10.1007/s004180050141CrossRefPubMed Burk RF, Hill KE, Boeglin ME, Ebner FF, Chittum HS: Selenoprotein P associates with endothelial cells in rat tissues. Histochem Cell Biol 1997, 108: 11-15. 10.1007/s004180050141CrossRefPubMed
12.
go back to reference Forceville X: Selenium and the 'free' electron. Selenium – a trace to be followed in septic or inflammatory ICU patients? Intensive Care Med 2001, 27: 16-18. 10.1007/s001340000779CrossRefPubMed Forceville X: Selenium and the 'free' electron. Selenium – a trace to be followed in septic or inflammatory ICU patients? Intensive Care Med 2001, 27: 16-18. 10.1007/s001340000779CrossRefPubMed
13.
go back to reference Olson OE: Selenium toxicity in animals with emphasis on man. J Am Coll Toxicol 1986, 5: 45-69.CrossRef Olson OE: Selenium toxicity in animals with emphasis on man. J Am Coll Toxicol 1986, 5: 45-69.CrossRef
14.
go back to reference Berger M: Nutrition of the stressed patient: which place for the micronutrients? Nutr Clin Métab 1998,12(Suppl 1):197S-209S. 10.1016/S0985-0562(98)80022-8CrossRef Berger M: Nutrition of the stressed patient: which place for the micronutrients? Nutr Clin Métab 1998,12(Suppl 1):197S-209S. 10.1016/S0985-0562(98)80022-8CrossRef
15.
go back to reference Spallholz JE: Free radical generation by selenium compounds and their prooxidant toxicity. Biomed Environ Sci 1997, 10: 260-270.PubMed Spallholz JE: Free radical generation by selenium compounds and their prooxidant toxicity. Biomed Environ Sci 1997, 10: 260-270.PubMed
16.
go back to reference Stewart MS, Spallholz JE, Neldner KH, Pence BC: Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med 1999, 26: 42-48. 10.1016/S0891-5849(98)00147-6CrossRefPubMed Stewart MS, Spallholz JE, Neldner KH, Pence BC: Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med 1999, 26: 42-48. 10.1016/S0891-5849(98)00147-6CrossRefPubMed
17.
go back to reference Carter RF: Acute selenium poisoning. Med J Aust 1966, 525-528. Carter RF: Acute selenium poisoning. Med J Aust 1966, 525-528.
18.
go back to reference Forceville X, Chancerelle Y, Agay D, Ducros V, Laporte F: At moderately high level, sodium selenium seems to decrease mortality in lipopolysaccharide rat model. [Abstract]. Intensive Care Med 2004,30(Suppl 1):S110. Forceville X, Chancerelle Y, Agay D, Ducros V, Laporte F: At moderately high level, sodium selenium seems to decrease mortality in lipopolysaccharide rat model. [Abstract]. Intensive Care Med 2004,30(Suppl 1):S110.
19.
go back to reference Kuklinski B, Buchner M, Schweder R, Nagel R: Acute pancreatitis – a 'free radical disease'. Decrease of lethality by sodium selenite (Na 2 SeO 3 therapy). Z Gesamte Inn Med 1991, 46: 145-149.PubMed Kuklinski B, Buchner M, Schweder R, Nagel R: Acute pancreatitis – a 'free radical disease'. Decrease of lethality by sodium selenite (Na 2 SeO 3 therapy). Z Gesamte Inn Med 1991, 46: 145-149.PubMed
20.
go back to reference Zimmermann T, Albrecht S, Kuhne H, Vogelsang U, Grutzmann R, Kopprasch S: Selenium administration in patients with sepsis syndrome. A prospective randomized study. Med Klin 1997, 92: 3-4.CrossRef Zimmermann T, Albrecht S, Kuhne H, Vogelsang U, Grutzmann R, Kopprasch S: Selenium administration in patients with sepsis syndrome. A prospective randomized study. Med Klin 1997, 92: 3-4.CrossRef
Metadata
Title
Seleno-enzymes and seleno-compounds: the two faces of selenium
Author
Xavier Forceville
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Critical Care / Issue 6/2006
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc5109

Other articles of this Issue 6/2006

Critical Care 6/2006 Go to the issue